论文部分内容阅读
目的探讨盐酸氨溴索针剂 (沐舒坦 )治疗早产儿肺炎的疗效。方法应用盐酸氨溴索针剂治疗 49例早产儿肺炎患儿。结果临床疗效治疗组总有效率 89.8% ,对照组总有效率 66.1% ,两组有显著性差异 (P<0 .0 1)。治疗组的住院时间为 (7.9± 3 .2 )天 ,对照组为(12 .4± 2 .5 )天 ,两组住院时间有显著性差异 (P<0 .0 1)。结论盐酸氨溴索针治疗早产儿肺炎疗效满意 ,且未见明显毒副作用 ,值得在临床上探索应用。
Objective To investigate the efficacy of ambroxol hydrochloride in the treatment of pneumonia in premature infants. Methods Ambroxol hydrochloride injection was used to treat 49 cases of pneumonia in premature infants. Results The total effective rate was 89.8% in the treatment group and 66.1% in the control group. There was significant difference between the two groups (P <0.01). The hospitalization duration was (7.9 ± 3.2 days) in the treatment group and (12.4 ± 2.5 days) in the control group, and the length of stay in the two groups was significantly different (P <0.01). Conclusion Ambroxol hydrochloride for the treatment of pneumonia in premature children is satisfactory, and no obvious side effects, it is worth exploring in the clinical application.